Might cannabis smoking contribute to bullous lung disease?

Büllöz akciğer hastalığı bleb, bül ve amfizem ile karak-terize olup, nadir ve yeni bir hastalık değildir. Büllöz amfizem hastalarının çoğu sigara kullanıcısıdır. Öte yandan esrar kullanımının büllöz akciğer hastalığına ve pnömotoraksa sebep olduğu bilinen bir gerçektir. Esrar kullanım sıklığı özellikle 19-32 yaş arası genç erişkinlerde, lise ve üniversite öğrencilerinde artmaktadır. Genç erişkin popülasyonda akciğer amfizemine bağlı sekonder pnömotoraks sıklığı beklenmedik bir şekilde artış göstermektedir. Burada, toraks tomografisinde her iki akciğer apeksinde küçük büllöz amfizematöz değişiklikler tespit ettiğimiz, 8 yıldır esrar kullanan spontan pnömotoraks olgusunu sunduk. Genç erişkin yaş grubunda esrar kullanımı sonucu büllöz amfizematöz değişiklikler oluşabileceğini ve bu duruma bağlı olarak sekonder spontan pnömotoraks sıklığının arttığını düşünmekteyiz.

Esrar kullanımı büllöz akciğer hastalığına sebep olabilir mi?

Bullous lung disease is characterized by formation of blebs, bullae and emphysema and it is neither a rare nor a new disease. Most patients with bullous emphysema are cigarette smokers. On the other hand cannabis smoking is common and appears on teaching a cause of bullous lung disease and pneumothorax. The prevalence of cannabis smoking has increased continuously in high school and college students, as well as in young adults aged 19-32 years. A surprising increase in the number of young adults with secondary pneumothorax due to lung emphysema was observed. Here, we report a case of spontaneous pneumothorax with bullous lesions who has been smoking cannabis over 8 years. We detected bilateral small bullous emphysematous changes in the apices of lung on computed thomography. We think that cannabis smoking might be cause of bullous emphysematous changes in the apices of lung and it is a reason of secondary spontaneous pneumothorax of young adults.

PDF

___

1. Bostancı K, Özyurtkan MO, Ahıskalı R, Polat O, Yüksel M. Bullous Lung Disease and Cigarette Smoking: A Postmortem Study. Marmara Medical Journal 2005;18: 123-8.
2. Klingman RR, Angelillo VA, DeMeester TR. Cystic and bullous lung disease. Ann Thorac Surg 1991;52: 576-80.
3. Greenberg JA, Singhal S, Kaiser LR. Giant bullous lung disease: Evaluation, selection, techniques, and outcome. Chest Surg Clin N Am 2003;13: 631-49.
4. Tan C, Hatam N, Treasure T. Bullous disease of the lung and cannabis smoking: insufficient evidence for a causative link. J R Soc Med 2006;99: 77-80.
5. Wesley JR, Macleod WM, Mullard KS. Evaluation and surgery of bullous emphysema. J Thorac Cardiovasc Surg 1972;63: 945-55.
6. Morgan MD, Denison DM, Strickland B. Value of computed tomography for selecting patients with bullous lung disease for surgery. Thorax 1986;41: 855-62.
7. Woo-ming L, Capel L, Belcher JR. The results of surgical treatment of large air cysts of the lung. Br J Dis Chest 1963;57: 79-85.
8. Keller CA. Pathophysiology and classification of emphysema. Chest Surg Clin N Am 2003;13: 589-613.
9. Hartmann TE, Tazelaar HD, Swensen SJ, Muller NL. Cigarette smoking: CT and pathologic findings of associated pulmonary diseases. Radiographics 1997;17: 377-90.
10. Sedrakyan A, van der Meulen J, Lewsey J, Treasure T. Video assisted thoracic surgery for treatment of pneumothorax and lung resections: systematic review of randomised clinical trials. BMJ 2004;329: 1008.
11. Beshay M, Kaiser H, Niedhart D, Marc A Reymond, Ralph A Schmid. Emphysema and secondary pneumothorax in young adults smoking cannabis. Eur J Cardiothorac Surg 2007;32: 834-38.
12. Segal J, Young B. Superinfected Pulmonary Bulla in a Freebase Cocaine User Canadian Journal of General Internal Medicine May 2009;4: 88-9
13. Morgan MD, Edwards CW, Morris J, Matthews HR. Origin and behaviour of emphysematous bullae. Thorax 1989;44: 533-38.
14. Baldwin GC, Choi R, Roth MD, Shay AH, Kleerup EC. Simmons MS.et al. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal (“crack”) cocaine. Chest 2002;121:1231-38.
15. Tashkin PD. Airway effects of marijuana, cocaine, and other illicit agents. Curr Opin Pulm Med 2001;7:43-61.
16. Susskind H, Weber DA, Volkow ND, Hitzemann R. Increased lung permeability following long-term use of free-base cocaine (crack). Chest 1991;100: 903-9.
17. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest 1997;112: 319-26.
18. Tashkin DP, Coulson AH, Clark VA, Simmons M. Bourque LB. Duann S, et al. Respiratory symptoms and lung function in habitual heavy smokers of marijuana alone, smokers of marijuana and tobacco, smokers of tobacco alone, and nonsmokers. Am Rev Respir Dis 1987;135: 209-16.
19. Johnston LD, O’Malley PM, Bachman JG. Monitoring the future national results on adolescent drug use: overview of key findings, 2001. Bethesda, Maryland: National Institute on Drug Abuse; 2002.
20. Health Canada. Cocaine use: recommendations in treatment and rehabilitation. Ottawa, ON: Health Canada, 2000; June 2008; 20.
21. Haim DY, Lippmann ML, Goldberg SK, Walkenstein MD. The pulmonary complications of crack cocaine. Chest 1995;107: 233-40.
22. Bense L, Eklund G, Wiman LG. Smoking and the increased risk of contracting spontaneous pneumothorax. Chest 1987;92: 1009-12.
23. Shesser R, Davis C, Edelstein S. Pneumomediastinum and pneumothorax after inhaling alkaloidal cocaine. Ann Emerg Med 1981;10: 213-15.
24. Mattox KL. Pneumomediastinum in heroin and marijuana users. JACEP 1976;5: 26-8.
25. Miller WE, Spiekerman RE, Hepper NG. Pneumomediastinum resulting from performing Valsalva maneuvers during marihuana smoking. Chest 1972;62: 233-4.
26. Goodyear K, Laws D, Turner J. Bilateral spontaneous pneumothorax in a cannabis smoker. J R Soc Med 2004;97: 435-6.
27. Hıı SW, Tam Jeff DC, Thompson BR, Naughton MT. Bullous lung disease due to marijuana Respirology 2008;13: 122-7.
28. Johnson MK, Smith RP, Morrison D, Laszlo G, White RJ. Large lung bullae in marijuana smokers. Thorax 2000;55: 340-2.
29. Thompson CS, White RJ. Lung bullae and marijuana. Thorax 2002;57: 563.
30. Taylor DR, Hall W. Respiratory health effects of cannabis: position statement of the Thoracic Society of Australia and New Zealand. Intern Med J 2003;33: 310-3.
31. Iversen L, Snyder SH. The science of marijuana. Oxford: Oxford University Press; 2000.
32. Morgan DR. Therapeutic uses of cannabis. London: Harwood Academic;1997.
33. Vachon L, FitzGerald MX, Solliday NH, Gould IA, Gaensler EA. Single-dose effects of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. N Engl J Med 1973;288: 985-9.
34. Tashkin DP, Shapiro BJ, Frank IM. Acute pulmonary physiologic effects of smoked marijuana and oral 9-tetrahydrocannabinol in healthy young men. N Engl J Med 1973;289: 336-41.
35. Coutts AA, Pertwee RG. Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus. Br J Pharmacol 1997;121: 1557-66.
36. Taylor DR, Poulton R, Moffitt TE, Ramankutty P, Sears MR. The respiratory effects of cannabis dependence in young adults. Addiction 2000;95: 1669-77.
37. Bloom JW, Kaltenborn WT, Paoletti P, Camilli A, Lebowitz MD. Respiratory effects of non-tobacco cigarettes. Br Med J (Clin Res Ed) 1987;295: 1516-18.